IS6970A - Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP - Google Patents

Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP

Info

Publication number: IS6970A
Authority: IS; Iceland
Prior art keywords: drug; alpha; toluidide; pvp; trifluoro
Prior art date: 2001-04-02

Application number

IS6970A

Other languages

English (en)

Inventor

Kay Cahill Julie

Frances Bateman Nicola

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-02

Filing date

2003-09-29

Publication date

2003-09-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27354679&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS6970(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-02 Priority claimed from SE0101171A external-priority patent/SE0101171D0/xx

2001-09-04 Priority claimed from SE0102957A external-priority patent/SE0102957D0/xx

2001-10-25 Priority claimed from SE0103565A external-priority patent/SE0103565D0/xx

2003-09-29 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-09-29 Publication of IS6970A publication Critical patent/IS6970A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS6970A 2001-04-02 2003-09-29 Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP IS6970A (is)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
SE0101171A SE0101171D0 (sv)	2001-04-02	2001-04-02	Pharmaceutical formulation
SE0102957A SE0102957D0 (sv)	2001-09-04	2001-09-04	Pharmaceutical formulation
SE0103565A SE0103565D0 (sv)	2001-10-25	2001-10-25	Pharmaceutical formulation
PCT/GB2002/001439 WO2002080902A1 (en)	2001-04-02	2002-03-27	Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp

Publications (1)

Publication Number	Publication Date
IS6970A true IS6970A (is)	2003-09-29

Family

ID=27354679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6970A IS6970A (is)	2001-04-02	2003-09-29	Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP

Country Status (21)

Country	Link
US (1)	US20040138299A1 (is)
EP (1)	EP1381358B1 (is)
JP (1)	JP2004525164A (is)
KR (1)	KR20030087048A (is)
CN (1)	CN1536993A (is)
AT (1)	ATE324886T1 (is)
BR (1)	BR0208421A (is)
CA (1)	CA2443040A1 (is)
CZ (1)	CZ20032647A3 (is)
DE (1)	DE60211139T2 (is)
EE (1)	EE200300476A (is)
ES (1)	ES2261655T3 (is)
HU (1)	HUP0303454A3 (is)
IL (1)	IL157955A0 (is)
IS (1)	IS6970A (is)
MX (1)	MXPA03008999A (is)
NO (1)	NO20034386L (is)
NZ (1)	NZ528284A (is)
PL (1)	PL365330A1 (is)
SK (1)	SK12032003A3 (is)
WO (1)	WO2002080902A1 (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1368001B1 (en) *	2001-02-27	2005-10-26	AstraZeneca AB	Pharmaceutical formulation comprising bicalutamide
SE0103424D0 (sv) *	2001-10-15	2001-10-15	Astrazeneca Ab	Pharmaceutical formulation
SE0103838D0 (sv) *	2001-11-16	2001-11-16	Astrazeneca Ab	Pharmaceutical formulation & product
US20050008691A1 (en) *	2003-05-14	2005-01-13	Arturo Siles Ortega	Bicalutamide compositions
KR20130041385A (ko) *	2004-11-29	2013-04-24	노파르티스 아게	Ｓ１ｐ 수용체 효능제의 투여 용법
JP2008531531A (ja) *	2005-02-23	2008-08-14	アストラゼネカアクチボラグ	方法
US7785629B2 (en) *	2005-06-21	2010-08-31	Helm Ag	Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof
US20070026073A1 (en) *	2005-07-28	2007-02-01	Doney John A	Amorphous efavirenz and the production thereof
US20080045600A1 (en) *	2006-08-17	2008-02-21	Gawande Rahul S	Bicalutamide compositions
US20080152717A1 (en) *	2006-12-14	2008-06-26	Isp Investments, Inc.	Amorphous valsartan and the production thereof
US10189957B2 (en) *	2007-01-26	2019-01-29	Isp Investments Llc	Formulation process method to produce spray dried products
HRP20170246T4 (hr)	2008-03-17	2020-02-07	Actelion Pharmaceuticals Ltd.	Režim doziranja za selektivni agonist s1p1-receptora
US9018253B2 (en)	2010-07-02	2015-04-28	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamate compound and muscle relaxant containing the same
CN103282346B (zh)	2011-01-13	2014-11-19	比皮艾思药物研发有限公司	用于制备苯基氨基甲酸酯衍生物的方法
JP6089045B2 (ja)	2011-12-27	2017-03-01	バイオ−ファームソリューションズカンパニーリミテッド	痛みの緩和または治療に使用するためのフェニルカルバメート化合物
TW201431570A (zh)	2012-11-22	2014-08-16	Ucb Pharma Gmbh	用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
CA2916183C (en)	2013-07-03	2022-03-29	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system with electronic component
WO2015177204A1 (en) *	2014-05-20	2015-11-26	Lts Lohmann Therapie-Systeme Ag	Transdermal delivery system containing rotigotine
CA2948221C (en)	2014-05-20	2022-11-22	Lts Lohmann Therapie-Systeme Ag	Transdermal delivery system including an interface mediator
WO2015177209A1 (en)	2014-05-20	2015-11-26	Lts Lohmann Therapie-Systeme Ag	Method for adjusting the release of active agent in a transdermal delivery system
KR102348325B1 (ko)	2014-12-05	2022-01-06	아라곤 파마슈티컬스, 인코포레이티드	항암 조성물
TWI709403B (zh)	2014-12-05	2020-11-11	美商艾瑞岡醫藥公司	抗癌症組成物（二）
PL3226841T3 (pl)	2014-12-05	2025-03-03	Aragon Pharmaceuticals, Inc.	Kompozycje przeciwnowotworowe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995019770A1 (en) *	1994-01-21	1995-07-27	Sepracor, Inc.	Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
DE60039379D1 (de) *	1999-02-10	2008-08-21	Pfizer Prod Inc	Pharmazeutische feste Dispersionen
GB9930839D0 (en) *	1999-12-30	2000-02-16	Pharmacia & Upjohn Spa	Process for treating gynecomastia

2002
- 2002-03-27 EE EEP200300476A patent/EE200300476A/xx unknown
- 2002-03-27 MX MXPA03008999A patent/MXPA03008999A/es unknown
- 2002-03-27 CN CNA028077474A patent/CN1536993A/zh active Pending
- 2002-03-27 SK SK1203-2003A patent/SK12032003A3/sk unknown
- 2002-03-27 KR KR10-2003-7012900A patent/KR20030087048A/ko not_active Withdrawn
- 2002-03-27 US US10/473,709 patent/US20040138299A1/en not_active Abandoned
- 2002-03-27 EP EP02718317A patent/EP1381358B1/en not_active Revoked
- 2002-03-27 CA CA002443040A patent/CA2443040A1/en not_active Abandoned
- 2002-03-27 NZ NZ528284A patent/NZ528284A/en unknown
- 2002-03-27 CZ CZ20032647A patent/CZ20032647A3/cs unknown
- 2002-03-27 PL PL02365330A patent/PL365330A1/xx not_active Application Discontinuation
- 2002-03-27 JP JP2002578941A patent/JP2004525164A/ja active Pending
- 2002-03-27 DE DE60211139T patent/DE60211139T2/de not_active Expired - Fee Related
- 2002-03-27 BR BR0208421-0A patent/BR0208421A/pt not_active IP Right Cessation
- 2002-03-27 WO PCT/GB2002/001439 patent/WO2002080902A1/en not_active Ceased
- 2002-03-27 AT AT02718317T patent/ATE324886T1/de not_active IP Right Cessation
- 2002-03-27 ES ES02718317T patent/ES2261655T3/es not_active Expired - Lifetime
- 2002-03-27 HU HU0303454A patent/HUP0303454A3/hu unknown
- 2002-03-27 IL IL15795502A patent/IL157955A0/xx unknown
2003
- 2003-09-29 IS IS6970A patent/IS6970A/is unknown
- 2003-10-01 NO NO20034386A patent/NO20034386L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1536993A (zh)	2004-10-13
CA2443040A1 (en)	2002-10-17
US20040138299A1 (en)	2004-07-15
WO2002080902A1 (en)	2002-10-17
ATE324886T1 (de)	2006-06-15
IL157955A0 (en)	2004-03-28
HUP0303454A2 (hu)	2004-01-28
EP1381358B1 (en)	2006-05-03
PL365330A1 (en)	2004-12-27
NZ528284A (en)	2005-04-29
CZ20032647A3 (cs)	2004-09-15
DE60211139D1 (de)	2006-06-08
ES2261655T3 (es)	2006-11-16
DE60211139T2 (de)	2007-03-01
NO20034386L (no)	2003-11-28
NO20034386D0 (no)	2003-10-01
BR0208421A (pt)	2004-03-30
SK12032003A3 (sk)	2004-03-02
KR20030087048A (ko)	2003-11-12
EP1381358A1 (en)	2004-01-21
EE200300476A (et)	2003-12-15
HUP0303454A3 (en)	2005-12-28
JP2004525164A (ja)	2004-08-19
MXPA03008999A (es)	2004-02-12

Publication	Publication Date	Title
IS6970A (is)	2003-09-29	Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP
WO2002067893A3 (en)	2003-01-16	Pharmaceutical formulation comprising bicalutamide
IL154888A (en)	2013-12-31	Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
ATE442142T1 (de)	2009-09-15	Fredericamycin-derivate als arzneimittel zur tumorbehandlung
CY1109681T1 (el)	2014-08-13	Υποκατεστημενα παραγωγα κιναζολινης ως αναστολεις των κινασων aurora
HU0102039D0 (en)	2001-07-30	Use of paclitaxel stabilized with albumin for the preparation of pharmaceutical compositions treating solid tumors and the pharmaceutical compositions obtained thereby
ATE468332T1 (de)	2010-06-15	Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate
GEP20053673B (en)	2005-11-25	Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
NO20034204D0 (no)	2003-09-22	Farmasöytiske kombinasjoner til behandling av kreft
MXPA05011076A (es)	2006-01-24	Derivados de quinazolina para el tratamiento de cancer.
DK1256339T3 (da)	2004-02-09	Transdermalt terapeutisk system for opnåelse af høje plasmaniveauer af rotigotin i behandlingen af Parkinsons sygdom
SE0101932D0 (sv)	2001-05-31	Pharmaceutical combinations
TW200505452A (en)	2005-02-16	Chemical compounds
ATE478662T1 (de)	2010-09-15	Arzneilösungen enthaltend modafinilverbindungen
SE0103424D0 (sv)	2001-10-15	Pharmaceutical formulation
SE0102440D0 (sv)	2001-07-05	New compound
SE0103839D0 (sv)	2001-11-16	Pharmaceutical formulation & product
DE60222383D1 (de)	2007-10-25	Medikament zur verabreichung von amifostin und verwandten wirkstoffen
MXPA04001912A (es)	2004-07-23	Aminobenzofenonas novedosas.
GEP201606538B (en)	2016-09-12	Preoperative treatment of post operative pain
SE0103838D0 (sv)	2001-11-16	Pharmaceutical formulation & product
NO20026032D0 (no)	2002-12-16	Farnesyltransferasehemmende 1,2-annelert kinolinenantiomer
SE0102887D0 (sv)	2001-08-29	New formulation
DK1071425T3 (da)	2007-12-27	Behandling af depression og farmaceutiske præparater dertil
BR0213463A (pt)	2004-11-09	Composições farmacêuticas contendo macrólidos